Bispecific anti-ErbB-3/anti-c-Met antibodies

Details for Australian Patent Application No. 2010233994 (hide)

Owner Roche Glycart AG

Inventors Bossenmaier, Birgit; Brinkman, Ulrich; Dormeyer, Wilma; Hoffmann, Eike; Klein, Christian; Niederfellner, Gerhard; Schanzer, Juergen Michael; Stracke, Jan Olaf; Sustmann, Claudio; Umana, Pablo

Agent Davies Collison Cave

Pub. Number AU-A-2010233994

PCT Pub. Number WO2010/115552

Priority 09005110.3 07.04.09 EP

Filing date 30 March 2010

Wipo publication date 14 October 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

22 September 2011 PCT application entered the National Phase

  PCT publication WO2010/115552 Priority application(s): WO2010/115552

12 July 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Roche Glycart AG, Application No. 2010233994, under INID (72) correct the co-inventor to Brinkmann, Ulrich

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010233995-Bispecific anti-ErbB-2/anti-c-Met antibodies

2010233993-Bispecific anti-ErbB-1/anti-c-Met antibodies